These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35214652)

  • 21. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection.
    Costanzo M; De Giglio MAR; Roviello GN
    Curr Med Chem; 2022; 29(1):4-18. PubMed ID: 34355678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers.
    Salvagno GL; Henry BM; Pighi L; de NS; Lippi G
    J Med Biochem; 2022 Apr; 41(2):199-203. PubMed ID: 35510202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Results of Five SARS-CoV-2 Antibody Assays before and after the First and Second ChAdOx1 nCoV-19 Vaccinations among Health Care Workers: a Prospective Multicenter Study.
    Jeong S; Lee N; Lee SK; Cho EJ; Hyun J; Park MJ; Song W; Jung EJ; Woo H; Seo YB; Park JJ; Kim HS
    J Clin Microbiol; 2021 Nov; 59(12):e0178821. PubMed ID: 34613799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
    Lopez Bernal J; Andrews N; Gower C; Robertson C; Stowe J; Tessier E; Simmons R; Cottrell S; Roberts R; O'Doherty M; Brown K; Cameron C; Stockton D; McMenamin J; Ramsay M
    BMJ; 2021 May; 373():n1088. PubMed ID: 33985964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
    Costa Clemens SA; Weckx L; Clemens R; Almeida Mendes AV; Ramos Souza A; Silveira MBV; da Guarda SNF; de Nobrega MM; de Moraes Pinto MI; Gonzalez IGS; Salvador N; Franco MM; de Avila Mendonça RN; Queiroz Oliveira IS; de Freitas Souza BS; Fraga M; Aley P; Bibi S; Cantrell L; Dejnirattisai W; Liu X; Mongkolsapaya J; Supasa P; Screaton GR; Lambe T; Voysey M; Pollard AJ;
    Lancet; 2022 Feb; 399(10324):521-529. PubMed ID: 35074136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Antibody Kinetics Following COVID-19 Vaccination in Greek SARS-CoV-2 Infected and Naïve Healthcare Workers.
    Pavlidis G; Giannoulis V; Pirounaki M; Lampropoulos IC; Siafi E; Nitsa A; Pavlou E; Xanthaki A; Perlepe G; Fortis SP; Charalambous G; Kampolis CF; Pantazopoulos I
    J Pers Med; 2023 May; 13(6):. PubMed ID: 37373899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and efficacy of          heterologous ChAdOx1-BNT162b2 vaccination.
    Pozzetto B; Legros V; Djebali S; Barateau V; Guibert N; Villard M; Peyrot L; Allatif O; Fassier JB; Massardier-Pilonchéry A; Brengel-Pesce K; Yaugel-Novoa M; Denolly S; Boson B; Bourlet T; Bal A; Valette M; Andrieu T; Lina B; ; Cosset FL; Paul S; Defrance T; Marvel J; Walzer T; Trouillet-Assant S
    Nature; 2021 Dec; 600(7890):701-706. PubMed ID: 34673755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers].
    Rojkovich B; Németh D; Török E; Szabó B; Pintér Á; Juhász I; Weidl M; Lányi É; Pável-Szecskó J; Lázár I; Perduk A; Reiter J; Nagy G; Nagy E; Géher P
    Orv Hetil; 2021 Sep; 162(39):1551-1557. PubMed ID: 34570721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral and Cellular Immunogenicity of Six Different Vaccines against SARS-CoV-2 in Adults: A Comparative Study in Tunisia (North Africa).
    Ben Ahmed M; Bellali H; Gdoura M; Zamali I; Kallala O; Ben Hmid A; Hamdi W; Ayari H; Fares H; Mechri K; Marzouki S; Triki H; Ben Alaya N; Chahed MK; Klouz A; Sebai Ben Amor S; Ben Rayana C; Razgallah Khrouf M; Hamouda C; Elkadri N; Daghfous R; Trabelsi A
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-SARS-CoV-2 Neutralizing Antibody Responses after Two Doses of ChAdOx1 nCoV-19 vaccine (AZD1222) in Healthcare Workers.
    Lim S; Lee Y; Kim DW; Park WS; Yoon JH; Lee JY
    Infect Chemother; 2022 Mar; 54(1):140-152. PubMed ID: 35384425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 epidemiology, antibody dynamics, and neutralisation capacity in Irish healthcare workers in the era of booster COVID-19 vaccinations.
    McGrath J; Kenny C; Nielsen CS; Domegan L; Walsh C; Rooney P; Walsh S; Conlon N; Brady G; Ibrahim A; Dunne J; McCormack W; Corcoran N; Allen N; Fleming C; Bergin C
    Front Med (Lausanne); 2023; 10():1078022. PubMed ID: 36778745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Third Dose of Pfizer/BioNTech and Moderna COVID-19 mRNA Vaccines on IgG Antibody Titers.
    Khuc TA; Pequeno G; Betancourt-Garcia M; Casciato AM; Gomez-Martinez M; Arroyo CD; Pope BD; Narmala S; Rao S
    Cureus; 2023 Jul; 15(7):e41696. PubMed ID: 37575726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification and Progress Over Time of Specific Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 in Breast Milk of Lactating Women Vaccinated With BNT162b2 Pfizer-BioNTech Coronavirus Disease 2019 Vaccine (LacCOVID).
    Esteve-Palau E; Gonzalez-Cuevas A; Guerrero ME; Garcia-Terol C; Alvarez MC; Garcia G; Moreno E; Medina F; Casadevall D; Diaz-Brito V
    Open Forum Infect Dis; 2022 Jun; 9(6):ofac239. PubMed ID: 35783685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization.
    Wiest NE; Johns GS; Edwards E
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls.
    Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY
    J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.
    Havervall S; Marking U; Greilert-Norin N; Ng H; Gordon M; Salomonsson AC; Hellström C; Pin E; Blom K; Mangsbo S; Phillipson M; Klingström J; Hober S; Nilsson P; Åberg M; Thålin C
    EBioMedicine; 2021 Aug; 70():103523. PubMed ID: 34391088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines.
    Szczepanek J; Skorupa M; Goroncy A; Jarkiewicz-Tretyn J; Wypych A; Sandomierz D; Jarkiewicz-Tretyn A; Dejewska J; Ciechanowska K; Pałgan K; Rajewski P; Tretyn A
    Vaccines (Basel); 2022 Jan; 10(1):. PubMed ID: 35062760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination.
    Kim N; Minn D; Park S; Roh EY; Yoon JH; Park H; Shin S
    J Korean Med Sci; 2021 May; 36(21):e158. PubMed ID: 34060264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA.
    Danese E; Montagnana M; Salvagno GL; Gelati M; Peserico D; Pighi L; de Nitto S; Henry BM; Porru S; Lippi G
    J Med Biochem; 2021 Sep; 40(4):335-340. PubMed ID: 34616223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.